Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

In patients with dry eye disease, Miebo before cataract surgery had no impact on the accuracy of preoperative measurements ...

The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will ...

Eye drops for presbyopia represent a major opportunity for patients, but their reception by eye care professionals since the ...

IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global ...

USA: A small-volume ophthalmic spray delivering mydriatic medications may offer a child-friendly alternative to traditional eye drops for pupillary dilation, a randomized clinical trial published in ...

The offering is expected to close on February 18, 2026, subject to the satisfaction of customary closing conditions. Sidley Austin LLP served as counsel to Opus Genetics in connection with the ...

Glaukos Corporation activity on NYSE Composite highlights revenue growth, product expansion, and market response within the ophthalmic medical technology sector.

For decades, the city of Kota in Rajasthan has been synonymous with academic coaching, serving as the intense crucible for India's future engineers and doctors. However, a quiet but powerful ...

Stephenson, MD, FACS, shares insights on evolving LAL technology and best practices for managing the ocular surface before ...

Independent Clinical Trial Site Grows Through Excellence In Trial Compliance LOUISVILLE, KY, UNITED STATES, January 30, ...